Medical Doctor Program year 2025 Reported 2019–2025 Source: CMS Open Payments, 2026 publication

David Chen

Surgery Santa Monica, CA Medical Doctor

NPI 1760630057 CMS profile 352783

1304 15Th St Ste 102, Ste 102, Santa Monica, CA 90404

Open in the dashboard

General payments

$288,158

294 records reported · program years 2019–2025

Research payments

$6,500

Paid to them · 1 record reported · program years 2019–2025

Ownership & investment interest

$0

None reported

Through program year 2025, David Chen of Santa Monica, CA is reported in the CMS Open Payments database as having received $288,158 across 294 general payments and $6,500 in research payments paid to them.

No combined total General, research and ownership are kept apart. Each is reported under its own rules, and ownership is not money that moved at all but the value of a stake held. A meal, a clinical trial grant and a shareholding do not add up to anything meaningful, so this site does not add them.

General payments for this record sit in the 99th percentile of Surgery profiles with reported payments. Percentile describes the distribution, not the conduct.

By program year

8 rows
Year Kind Relative to this record's peak year Amount Records
2025 General $64,582 41
2025 Research $6,500 1
2024 General $72,725 69
2023 General $66,122 55
2022 General $40,572 84
2021 General $14,843 15
2020 General $14,668 5
2019 General $14,645 25

Beside peers

Year by year, beside peers General payments · among profiles paid that year
  • David Chen
  • Surgery median
  • Middle half of Surgery
  • National median

In program year 2025, general payments to David Chen were reported at $64,582. Among 17,702 Surgery profiles paid that year, the median was $280 and the middle half received between $91 and $1,259.

Show as a table
Year David Chen Surgery median Middle half National median
2019 $14,645 $253 $82–$1,521 $163
2020 $14,668 $131 $40–$706 $114
2021 $14,843 $168 $50–$904 $132
2022 $40,572 $224 $76–$1,218 $149
2023 $66,122 $253 $82–$1,255 $160
2024 $72,725 $279 $90–$1,381 $164
2025 $64,582 $280 $91–$1,259 $169

Breakdown

Who paid General payments · program years 2019–2025
  1. Medtronic, Inc. $213,932 164 payments
  2. Allergan Inc. $26,129 29 payments
  3. Covidien LP $16,142 14 payments
  4. AbbVie, Inc. $14,367 15 payments
  5. Intuitive Surgical, Inc. $13,285 31 payments
  6. Davol Inc. $3,145 26 payments
  7. Innocoll Incorporated $484 4 payments
  8. CONMED Corporation $233 2 payments
  9. Pacira Pharmaceuticals Incorporated $198 2 payments
  10. TELA Bio, Inc. $107 2 payments
  11. Other $137 5 payments

Every payment, record by record

What the payments were for General payments · program years 2019–2025
  1. Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program $136,013 29 payments
  2. Consulting Fee $104,357 21 payments
  3. Travel and Lodging $33,254 86 payments
  4. Food and Beverage $10,521 156 payments
  5. Education $4,000 1 payment
  6. Gift $14 1 payment
Products named General payments · program years 2019–2025
  1. AbsorbaTack $18,494 6 payments
  2. ProGrip Hernia Repair $17,105 43 payments
  3. Dextile $13,978 11 payments
  4. Da Vinci Surgical System $13,285 31 payments
  5. STRATTICE $13,128 13 payments
  6. STRATTICE RECONSTRUCTIVE TISSUE MATRIX BPS $11,041 14 payments
  7. Phasix Mesh $1,475 9 payments
  8. ProGrip Hernia Repair $572 5 payments
  9. XARACOLL $484 4 payments
  10. Signia $443 4 payments
  11. Other $1,668 40 payments

A payment can name more than one product, so these amounts overlap and do not add up to the general-payment figure.

Research payments came from Research payments · program years 2019–2025
  1. Medtronic, Inc. $6,500 1 payment

Prescribing to Medicare patients

Part D · data year 2024 · 2 drugs

Part D claims

42

Median for General Practice: 1,105

Drug cost

$141

Median for General Practice: $48,734

Branded share of claims

0%

Median for General Practice: 17.1%

Drugs this doctor was counted under in Medicare Part D 2024, by drug cost
Drug Type Relative to their largest Claims Drug cost
Pantoprazole Sodium Generic 14 $77
Meloxicam Generic 28 $64

Drug cost is what was paid for the drugs at the pharmacy — by Medicare, the patient and others — and is not money to the prescriber. Medicare Part D only: drugs dispensed to Medicare beneficiaries. A drug with fewer than 11 claims for this prescriber is not published, so a missing drug does not mean zero. The medians are for the 7,210 Part D prescribers listed as General Practice; they describe a distribution and say nothing about conduct.

Billing to Medicare

Part B · data year 2024 · 109 billing codes

Paid by Medicare

$271,686

Medicare's payments for the services billed

Medicare patients

378

Average age 73

Services billed

908

143 women, 235 men among their patients

Share of this provider's Medicare patients with each condition
Condition among their Medicare patients Relative to the most common Share of patients
High blood pressure 67%
Arthritis 56%
Ischemic heart disease 37%
Chronic kidney disease 26%
Cancer 26%
Diabetes 25%
Depression 25%
Atrial fibrillation 19%

Medicare Part B only: services billed to Medicare. Rows covering fewer than 11 beneficiaries are not published. Only drugs given in the clinic are itemised here; the rest of what this provider billed is in the total above.

Payments and prescribing

1 product · payments 2024

Two separate records. The payments come from Open Payments and the claims from Medicare. They are set side by side because they name the same product; they do not show that a payment affected a prescription.

Products this doctor was paid in connection with in 2024, beside Medicare claims for the same product
Product Paid by Related payments Part D claims Part B services
Exparel
  • Pacira Pharmaceuticals Incorporated $198
$198 — —

A dash means Medicare published no figure for this doctor and product — fewer than 11 claims, or the product is not covered under that part — which is not the same as none. Payments are general payments only; one that names several products is split evenly between them, so an amount is payments related to the product, not money paid for it.

Records

295 reported

Every payment, record by record

Date, company, amount, what it was for and the product named — filter by year, kind and company, or download as CSV.

Other Surgery in California

Related records

What this means

U.S. law requires drug and medical device manufacturers to report payments and transfers of value they make to physicians and teaching hospitals. The Centers for Medicare & Medicaid Services publishes that record each year. This page shows what was reported about this person, and nothing else.

An ownership interest is different from the other two. It is not a payment: it is a stake — shares, options, a partnership holding — that a physician or an immediate family member held in a manufacturer during that year. The figure shown is what the stake was reported to be worth.

Research payments frequently pass through a clinician to the institution running a trial, and rarely represent personal income. They should be read differently from general payments.

Provenance

Source: CMS Open Payments · through program year 2025

Data current to program year 2025, from CMS's 2026 publication.

We reproduce what manufacturers reported. We do not verify, edit or correct the underlying records.

A payment record is not evidence of wrongdoing. Financial relationships between industry and medicine are legal, common and often necessary for research. Who Paid My Doc reports what was disclosed; it does not judge it.

Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency. It is not a consumer reporting agency and this is not a consumer report; do not use it for decisions covered by the Fair Credit Reporting Act.

How to dispute or correct a record